7 months ago

According to CoinDesk, South Korean DNA sequencing service provider Macrogen published a press release, announcing that it has cooperated with Big Data firm Bigster to develop a blockchain network for sharing genetic information by June 2019.

In the medical sphere genetic data is used for patient diagnosis and treatment, while the pharmaceutical industry can use it for creating new drugs and therapeutic agents. The companies will launch a system based on a consortium blockchain model that will only allow invited parties – such as pharmaceutical companies, research medical institutes, hospitals and genetic analysis startups.

Macrogen is not the first company planning to implement blockchain within the genomics sphere. In 2014, an Israeli startup DNA.Bits announced plans to store genomic and medical record data using blockchain technology.